Publications by authors named "Cristobal Gonzales-Losada"
Article Synopsis
- Scientists have been using special medicines called nucleoside analogs, like cytarabine, to treat a type of blood cancer called acute myeloid leukemia (AML) for many years.
- However, some patients don’t respond well to these medicines because their cancer cells become resistant to treatment.
- Researchers discovered that a protein named HERC1 affects how well these medicines work, and targeting HERC1 could help improve AML treatments in the future.
